Individuals who maintain a high level of fitness in midlife are at a decreased risk of depression—and those who stay in shape while diagnosed with depression exhibit a 56 percent lower risk of cardiovascular disease (CVD), according to new research published on June 27 in JAMA Psychiatry.

According to a new study published in the Journal of the American College of Cardiology, women with preeclampsia with severe features (PEC) have higher right ventricular (RV) systolic pressure (RVSP) and decreased global right ventricular longitudinal systolic strain (RVLSS), among other adverse cardiovascular events, compared to women not exhibiting preeclampsia during pregnancy.

Compared to warfarin, the direct oral anticoagulants (DOACs) apixaban, rivaroxaban and dabigatran are all associated with a reduced risk of myocardial infarction, according to a Danish registry study of consecutive patients with nonvalvular atrial fibrillation (AFib).

The thinking behind the Seattle Proportional Risk Model goes like this: As the annual risk for all-cause mortality increases, the likelihood that the death will be sudden—or something an ICD could prevent—goes down.

Sleep disturbances, including poor sleep quality and insomnia, are associated with increased blood pressure and vascular inflammation in women, according to a June 9 study in the Journal of the American Heart Association.

A new study published in Hypertension suggests tailoring blood pressure (BP) treatment to a patient’s exercise level may help, because people with elevated but controlled hypertension saw an increase in BP during physical activity.

Frequent binge drinkers—particularly men—are more likely to have cardiovascular risk factors such as hypertension and high cholesterol, according to a new study published in the Journal of the American Heart Association.

A triple therapy approach of warfarin, clopidogrel and aspirin substantially reduces the risk of ischemic stroke and stent thrombosis compared to dual antiplatelet therapy (DAPT), according to a meta-analysis of patients with atrial fibrillation (AFib) undergoing coronary stenting. However, the three-medication strategy is associated with a higher bleeding risk.